Janet Reed has had Multiple Sclerosis for 33 years. She's among many patients taking part in a study at the University of Rochester Medical Center to see if the drug Aricept can help her memory and concentration. Aricept is already used to treat Alzheimer's patients.
As yet, there is no drug treatment designed to help the memory trouble that comes with MS. Researchers are hopeful that Aricept will be effective in MS patients since the drug boosts the amount of a chemical in the brain called Acetylcholine. MS damage affects the pathways where Acetylcholine is transported through the brain.
Dr. Steve Schwid, a neurologist at the URMC, says "If those pathways are disrupted then the levels of Acetylcholine in the important areas of cognition will be reduced. Anything we can do to improve the availability of Acetylcholine in those area might improve their function."
Before the study, MS patients take memory tests to measure their abilities. After 12 weeks taking Aricept or a placebo, they're tested again. So far, the MS patients have shown substantial improvement, but the results from testing at some 20 medical centers around the country won't be compiled for about two years.
Having weight-loss surgery before you become severely obese tends to achieve better results, a new study finds.
A new surgical procedure can help people with shoulder injuries once considered beyond repair, a small new study suggests.
Ninety-nine percent of former NFL players who donated their brain to science turned out to have the devastating disorder chronic traumatic encephalopathy (CTE), according to a new report.
Most primary care doctors can't identify all 11 risk factors for prediabetes, a small new survey finds.